Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 84 entries
Sorted by: Best Match Show Resources per page
Combination of Complement-Dependent Cytotoxicity and Relative Fluorescent Quantification of HLA Length Polymorphisms Facilitates the Detection of a Loss of Heterozygosity.

Bone marrow research

Witter K, Reibke R, Subklewe M, Zahn R, Kauke T, Spiekermann K, Spannagl M, Tischer J, Hiddemann W, Dick A.
PMID: 24860670
Bone Marrow Res. 2014;2014:541345. doi: 10.1155/2014/541345. Epub 2014 Apr 03.

Loss of heterozygosity (LOH) is a common event in malignant cells. In this work we introduce a new approach to identify patients with loss of heterozygosity in the HLA region either at first diagnosis or after HLA mismatched allogeneic...

Cite
Witter K, Reibke R, Subklewe M, et al. Combination of Complement-Dependent Cytotoxicity and Relative Fluorescent Quantification of HLA Length Polymorphisms Facilitates the Detection of a Loss of Heterozygosity. Bone Marrow Res. 2014;2014:541345doi: 10.1155/2014/541345.
Witter, K., Reibke, R., Subklewe, M., Zahn, R., Kauke, T., Spiekermann, K., Spannagl, M., Tischer, J., Hiddemann, W., & Dick, A. (2014). Combination of Complement-Dependent Cytotoxicity and Relative Fluorescent Quantification of HLA Length Polymorphisms Facilitates the Detection of a Loss of Heterozygosity. Bone marrow research, 2014541345. https://doi.org/10.1155/2014/541345
Witter, Klaus, et al. "Combination of Complement-Dependent Cytotoxicity and Relative Fluorescent Quantification of HLA Length Polymorphisms Facilitates the Detection of a Loss of Heterozygosity." Bone marrow research vol. 2014 (2014): 541345. doi: https://doi.org/10.1155/2014/541345
Witter K, Reibke R, Subklewe M, Zahn R, Kauke T, Spiekermann K, Spannagl M, Tischer J, Hiddemann W, Dick A. Combination of Complement-Dependent Cytotoxicity and Relative Fluorescent Quantification of HLA Length Polymorphisms Facilitates the Detection of a Loss of Heterozygosity. Bone Marrow Res. 2014;2014:541345. doi: 10.1155/2014/541345. Epub 2014 Apr 03. PMID: 24860670; PMCID: PMC3996364.
Copy Download .nbib Format: NLM
Octreotide neutralizes dexamethasone antitumor actions on P388 murine lymphocytic leukemia in vivo.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Trafalis DT, Chrysogelou E, Dalezis P, Geromichalos G, Kontos M, Andreadis C, Ziras N, Koutsilieris M, Athanassiou AE, Pangalis GA, Papageorgiou A.
PMID: 17335137
J BUON. 2005 Jan-Mar;10(1):89-94.

PURPOSE: A wide variety of human malignancies, including lymphoproliferative neoplasms, express somatistatin (SS) receptors (SS-R). SS induces apoptosis and exerts pronounced antiproliferative effects on various human tumors cell lines, human xenografts, and animal tumors including P388 lymphocytic leukemia. In...

Cite
Trafalis DT, Chrysogelou E, Dalezis P, et al. Octreotide neutralizes dexamethasone antitumor actions on P388 murine lymphocytic leukemia in vivo. J BUON. 2005;10(1):89-94
Trafalis, D. T., Chrysogelou, E., Dalezis, P., Geromichalos, G., Kontos, M., Andreadis, C., Ziras, N., Koutsilieris, M., Athanassiou, A. E., Pangalis, G. A., & Papageorgiou, A. (2005). Octreotide neutralizes dexamethasone antitumor actions on P388 murine lymphocytic leukemia in vivo. Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 10(1), 89-94.
Trafalis, D T P, et al. "Octreotide neutralizes dexamethasone antitumor actions on P388 murine lymphocytic leukemia in vivo." Journal of B.U.ON. : official journal of the Balkan Union of Oncology vol. 10,1 (2005): 89-94.
Trafalis DT, Chrysogelou E, Dalezis P, Geromichalos G, Kontos M, Andreadis C, Ziras N, Koutsilieris M, Athanassiou AE, Pangalis GA, Papageorgiou A. Octreotide neutralizes dexamethasone antitumor actions on P388 murine lymphocytic leukemia in vivo. J BUON. 2005 Jan-Mar;10(1):89-94. PMID: 17335137.
Copy Download .nbib Format: NLM
Optimization of detection strategies for epithermal neutron spectroscopy using photon-sensitive detectors.

The Review of scientific instruments

Ulpiani P, Romanelli G, Onorati D, Parmentier A, Festa G, Schooneveld E, Cazzaniga C, Arcidiacono L, Andreani C, Senesi R.
PMID: 31370488
Rev Sci Instrum. 2019 Jul;90(7):073901. doi: 10.1063/1.5091084.

In this work, we discuss an improved detection procedure for the photon-sensitive yttrium-aluminum-perovskite detectors installed on the VESUVIO spectrometer at the ISIS pulsed neutron and muon source. By decreasing the low-level energy threshold of detected photons, we observe an...

Cite
Ulpiani P, Romanelli G, Onorati D, et al. Optimization of detection strategies for epithermal neutron spectroscopy using photon-sensitive detectors. Rev Sci Instrum. 2019;90(7):073901doi: 10.1063/1.5091084.
Ulpiani, P., Romanelli, G., Onorati, D., Parmentier, A., Festa, G., Schooneveld, E., Cazzaniga, C., Arcidiacono, L., Andreani, C., & Senesi, R. (2019). Optimization of detection strategies for epithermal neutron spectroscopy using photon-sensitive detectors. The Review of scientific instruments, 90(7), 073901. https://doi.org/10.1063/1.5091084
Ulpiani, Pierfrancesco, et al. "Optimization of detection strategies for epithermal neutron spectroscopy using photon-sensitive detectors." The Review of scientific instruments vol. 90,7 (2019): 073901. doi: https://doi.org/10.1063/1.5091084
Ulpiani P, Romanelli G, Onorati D, Parmentier A, Festa G, Schooneveld E, Cazzaniga C, Arcidiacono L, Andreani C, Senesi R. Optimization of detection strategies for epithermal neutron spectroscopy using photon-sensitive detectors. Rev Sci Instrum. 2019 Jul;90(7):073901. doi: 10.1063/1.5091084. PMID: 31370488.
Copy Download .nbib Format: NLM
Reconstruction of the orientational pair-correlation function from neutron-diffraction data: The case of liquid hydrogen iodide.

Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics

Andreani C, Nardone M, Soper AK.
PMID: 9960291
Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 1993 Apr;47(4):2598-2605. doi: 10.1103/physreve.47.2598.

No abstract available.

Cite
Andreani C, Nardone M, Soper AK. Reconstruction of the orientational pair-correlation function from neutron-diffraction data: The case of liquid hydrogen iodide. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 1993;47(4):2598-2605doi: 10.1103/physreve.47.2598.
Andreani, C., Nardone, M., & Soper, A. K. (1993). Reconstruction of the orientational pair-correlation function from neutron-diffraction data: The case of liquid hydrogen iodide. Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics, 47(4), 2598-2605. https://doi.org/10.1103/physreve.47.2598
Andreani, et al. "Reconstruction of the orientational pair-correlation function from neutron-diffraction data: The case of liquid hydrogen iodide." Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics vol. 47,4 (1993): 2598-2605. doi: https://doi.org/10.1103/physreve.47.2598
Andreani C, Nardone M, Soper AK. Reconstruction of the orientational pair-correlation function from neutron-diffraction data: The case of liquid hydrogen iodide. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 1993 Apr;47(4):2598-2605. doi: 10.1103/physreve.47.2598. PMID: 9960291.
Copy Download .nbib Format: NLM
Quantum and classical behavior of single-particle dynamics in dense liquid 4He.

Physical review. B, Condensed matter

Andreani C, Filabozzi A, Mayers J, Nardone M, Ricci FP.
PMID: 9975439
Phys Rev B Condens Matter. 1994 Nov 01;50(17):12744-12746. doi: 10.1103/physrevb.50.12744.

No abstract available.

Cite
Andreani C, Filabozzi A, Mayers J, et al. Quantum and classical behavior of single-particle dynamics in dense liquid 4He. Phys Rev B Condens Matter. 1994;50(17):12744-12746doi: 10.1103/physrevb.50.12744.
Andreani, C., Filabozzi, A., Mayers, J., Nardone, M., & Ricci, F. P. (1994). Quantum and classical behavior of single-particle dynamics in dense liquid 4He. Physical review. B, Condensed matter, 50(17), 12744-12746. https://doi.org/10.1103/physrevb.50.12744
Andreani, et al. "Quantum and classical behavior of single-particle dynamics in dense liquid 4He." Physical review. B, Condensed matter vol. 50,17 (1994): 12744-12746. doi: https://doi.org/10.1103/physrevb.50.12744
Andreani C, Filabozzi A, Mayers J, Nardone M, Ricci FP. Quantum and classical behavior of single-particle dynamics in dense liquid 4He. Phys Rev B Condens Matter. 1994 Nov 01;50(17):12744-12746. doi: 10.1103/physrevb.50.12744. PMID: 9975439.
Copy Download .nbib Format: NLM
The molecular link between oxidative stress, insulin resistance, and type 2 diabetes: A target for new therapies against cardiovascular diseases.

Current opinion in pharmacology

Andreadi A, Bellia A, Di Daniele N, Meloni M, Lauro R, Della-Morte D, Lauro D.
PMID: 34959126
Curr Opin Pharmacol. 2021 Dec 23;62:85-96. doi: 10.1016/j.coph.2021.11.010. Epub 2021 Dec 23.

Type 2 Diabetes Mellitus (T2D) is a chronic disease with a pandemic incidence whose pathogenesis has not yet been clarified. Raising evidence highlighted the role of oxidative stress in inducing insulin resistance, pancreatic beta-cell dysfunction, and leading to cardiovascular...

Cite
Andreadi A, Bellia A, Di Daniele N, et al. The molecular link between oxidative stress, insulin resistance, and type 2 diabetes: A target for new therapies against cardiovascular diseases. Curr Opin Pharmacol. 2021;62:85-96doi: 10.1016/j.coph.2021.11.010.
Andreadi, A., Bellia, A., Di Daniele, N., Meloni, M., Lauro, R., Della-Morte, D., & Lauro, D. (2021). The molecular link between oxidative stress, insulin resistance, and type 2 diabetes: A target for new therapies against cardiovascular diseases. Current opinion in pharmacology, 6285-96. https://doi.org/10.1016/j.coph.2021.11.010
Andreadi, Aikaterini, et al. "The molecular link between oxidative stress, insulin resistance, and type 2 diabetes: A target for new therapies against cardiovascular diseases." Current opinion in pharmacology vol. 62 (2021): 85-96. doi: https://doi.org/10.1016/j.coph.2021.11.010
Andreadi A, Bellia A, Di Daniele N, Meloni M, Lauro R, Della-Morte D, Lauro D. The molecular link between oxidative stress, insulin resistance, and type 2 diabetes: A target for new therapies against cardiovascular diseases. Curr Opin Pharmacol. 2021 Dec 23;62:85-96. doi: 10.1016/j.coph.2021.11.010. Epub 2021 Dec 23. PMID: 34959126.
Copy Download .nbib Format: NLM
Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I Trial.

Clinical lymphoma, myeloma & leukemia

Kambhampati S, Fakhri B, Ai WZ, Kaplan LD, Tuscano JM, Wieduwilt MJ, Sudhindra A, Cavallone E, Reiner J, Aoun C, Castillo M, Martinelli M, Ta T, Le D, Padilla M, Crawford E, Andreadis CB.
PMID: 33478921
Clin Lymphoma Myeloma Leuk. 2021 Mar;21(3):139-146. doi: 10.1016/j.clml.2020.12.020. Epub 2020 Dec 24.

INTRODUCTION: We designed a multicenter, phase Ib dose-escalation trial of carfilzomib with bendamustine and rituximab in patients with relapsed/refractory non-Hodgkin lymphoma (NCT02187133) in order to improve the response rates of this difficult-to-treat population. Chemoimmunotherapy with bendamustine and rituximab has...

Cite
Kambhampati S, Fakhri B, Ai WZ, et al. Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I Trial. Clin Lymphoma Myeloma Leuk. 2020;21(3):139-146doi: 10.1016/j.clml.2020.12.020.
Kambhampati, S., Fakhri, B., Ai, W. Z., Kaplan, L. D., Tuscano, J. M., Wieduwilt, M. J., Sudhindra, A., Cavallone, E., Reiner, J., Aoun, C., Castillo, M., Martinelli, M., Ta, T., Le, D., Padilla, M., Crawford, E., & Andreadis, C. B. (2021). Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I Trial. Clinical lymphoma, myeloma & leukemia, 21(3), 139-146. https://doi.org/10.1016/j.clml.2020.12.020
Kambhampati, Swetha, et al. "Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I Trial." Clinical lymphoma, myeloma & leukemia vol. 21,3 (2021): 139-146. doi: https://doi.org/10.1016/j.clml.2020.12.020
Kambhampati S, Fakhri B, Ai WZ, Kaplan LD, Tuscano JM, Wieduwilt MJ, Sudhindra A, Cavallone E, Reiner J, Aoun C, Castillo M, Martinelli M, Ta T, Le D, Padilla M, Crawford E, Andreadis CB. Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I Trial. Clin Lymphoma Myeloma Leuk. 2021 Mar;21(3):139-146. doi: 10.1016/j.clml.2020.12.020. Epub 2020 Dec 24. PMID: 33478921.
Copy Download .nbib Format: NLM
The molecular link between oxidative stress, insulin resistance, and type 2 diabetes: A target for new therapies against cardiovascular diseases.

Current opinion in pharmacology

Andreadi A, Bellia A, Di Daniele N, Meloni M, Lauro R, Della-Morte D, Lauro D.
PMID: 34959126
Curr Opin Pharmacol. 2021 Dec 23;62:85-96. doi: 10.1016/j.coph.2021.11.010. Epub 2021 Dec 23.

Type 2 Diabetes Mellitus (T2D) is a chronic disease with a pandemic incidence whose pathogenesis has not yet been clarified. Raising evidence highlighted the role of oxidative stress in inducing insulin resistance, pancreatic beta-cell dysfunction, and leading to cardiovascular...

Cite
Andreadi A, Bellia A, Di Daniele N, et al. The molecular link between oxidative stress, insulin resistance, and type 2 diabetes: A target for new therapies against cardiovascular diseases. Curr Opin Pharmacol. 2021;62:85-96doi: 10.1016/j.coph.2021.11.010.
Andreadi, A., Bellia, A., Di Daniele, N., Meloni, M., Lauro, R., Della-Morte, D., & Lauro, D. (2021). The molecular link between oxidative stress, insulin resistance, and type 2 diabetes: A target for new therapies against cardiovascular diseases. Current opinion in pharmacology, 6285-96. https://doi.org/10.1016/j.coph.2021.11.010
Andreadi, Aikaterini, et al. "The molecular link between oxidative stress, insulin resistance, and type 2 diabetes: A target for new therapies against cardiovascular diseases." Current opinion in pharmacology vol. 62 (2021): 85-96. doi: https://doi.org/10.1016/j.coph.2021.11.010
Andreadi A, Bellia A, Di Daniele N, Meloni M, Lauro R, Della-Morte D, Lauro D. The molecular link between oxidative stress, insulin resistance, and type 2 diabetes: A target for new therapies against cardiovascular diseases. Curr Opin Pharmacol. 2021 Dec 23;62:85-96. doi: 10.1016/j.coph.2021.11.010. Epub 2021 Dec 23. PMID: 34959126.
Copy Download .nbib Format: NLM
Impact, Screening, and Therapy of HLA Antibodies in Patients before and after Lung Transplantation.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie

Dick A, Humpe A, Kauke T.
PMID: 31832059
Transfus Med Hemother. 2019 Oct;46(5):337-347. doi: 10.1159/000502124. Epub 2019 Aug 20.

Since almost 30 years, lung transplantation is a considerable therapeutic option in patients suffering from end-stage lung disease. Up to now, the impact of donor-specific antibodies directed against donor HLA (human leukocyte antigen) before and after transplantation is still...

Cite
Dick A, Humpe A, Kauke T. Impact, Screening, and Therapy of HLA Antibodies in Patients before and after Lung Transplantation. Transfus Med Hemother. 2019;46(5):337-347doi: 10.1159/000502124.
Dick, A., Humpe, A., & Kauke, T. (2019). Impact, Screening, and Therapy of HLA Antibodies in Patients before and after Lung Transplantation. Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie, 46(5), 337-347. https://doi.org/10.1159/000502124
Dick, Andrea, et al. "Impact, Screening, and Therapy of HLA Antibodies in Patients before and after Lung Transplantation." Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie vol. 46,5 (2019): 337-347. doi: https://doi.org/10.1159/000502124
Dick A, Humpe A, Kauke T. Impact, Screening, and Therapy of HLA Antibodies in Patients before and after Lung Transplantation. Transfus Med Hemother. 2019 Oct;46(5):337-347. doi: 10.1159/000502124. Epub 2019 Aug 20. PMID: 31832059; PMCID: PMC6876583.
Copy Download .nbib Format: NLM
Ofatumumab, Etoposide, and Cytarabine Intensive Mobilization Regimen in Patients with High-risk Relapsed/Refractory Diffuse Large B-Cell Lymphoma Undergoing Autologous Stem Cell Transplantation.

Clinical lymphoma, myeloma & leukemia

Kambhampati S, Hunter B, Varnavski A, Fakhri B, Kaplan L, Ai WZ, Pampaloni M, Huang CY, Martin T, Damon L, Andreadis CB.
PMID: 33288485
Clin Lymphoma Myeloma Leuk. 2021 Apr;21(4):246-256.e2. doi: 10.1016/j.clml.2020.11.005. Epub 2020 Nov 11.

BACKGROUND: More than one-half of high-risk patients with relapsed/refractory (rr) diffuse large B-cell lymphoma (DLBCL) relapse after autologous hematopoietic cell transplantation (auto-HCT). In this phase II study, we investigate the long-term outcomes of high-risk patients with rrDLBCL receiving intensive...

Cite
Kambhampati S, Hunter B, Varnavski A, et al. Ofatumumab, Etoposide, and Cytarabine Intensive Mobilization Regimen in Patients with High-risk Relapsed/Refractory Diffuse Large B-Cell Lymphoma Undergoing Autologous Stem Cell Transplantation. Clin Lymphoma Myeloma Leuk. 2020;21(4):246-256.e2doi: 10.1016/j.clml.2020.11.005.
Kambhampati, S., Hunter, B., Varnavski, A., Fakhri, B., Kaplan, L., Ai, W. Z., Pampaloni, M., Huang, C. Y., Martin, T., Damon, L., & Andreadis, C. B. (2021). Ofatumumab, Etoposide, and Cytarabine Intensive Mobilization Regimen in Patients with High-risk Relapsed/Refractory Diffuse Large B-Cell Lymphoma Undergoing Autologous Stem Cell Transplantation. Clinical lymphoma, myeloma & leukemia, 21(4), 246-256.e2. https://doi.org/10.1016/j.clml.2020.11.005
Kambhampati, Swetha, et al. "Ofatumumab, Etoposide, and Cytarabine Intensive Mobilization Regimen in Patients with High-risk Relapsed/Refractory Diffuse Large B-Cell Lymphoma Undergoing Autologous Stem Cell Transplantation." Clinical lymphoma, myeloma & leukemia vol. 21,4 (2021): 246-256.e2. doi: https://doi.org/10.1016/j.clml.2020.11.005
Kambhampati S, Hunter B, Varnavski A, Fakhri B, Kaplan L, Ai WZ, Pampaloni M, Huang CY, Martin T, Damon L, Andreadis CB. Ofatumumab, Etoposide, and Cytarabine Intensive Mobilization Regimen in Patients with High-risk Relapsed/Refractory Diffuse Large B-Cell Lymphoma Undergoing Autologous Stem Cell Transplantation. Clin Lymphoma Myeloma Leuk. 2021 Apr;21(4):246-256.e2. doi: 10.1016/j.clml.2020.11.005. Epub 2020 Nov 11. PMID: 33288485.
Copy Download .nbib Format: NLM
Over-expressed, N-terminally truncated BRAF is detected in the nucleus of cells with nuclear phosphorylated MEK and ERK.

Heliyon

Hey F, Andreadi C, Noble C, Patel B, Jin H, Kamata T, Straatman K, Luo J, Balmanno K, Jones DTW, Collins VP, Cook SJ, Caunt CJ, Pritchard C.
PMID: 30603699
Heliyon. 2018 Dec 20;4(12):e01065. doi: 10.1016/j.heliyon.2018.e01065. eCollection 2018 Dec.

BRAF is a cytoplasmic protein kinase, which activates the MEK-ERK signalling pathway. Deregulation of the pathway is associated with the presence of

Cite
Hey F, Andreadi C, Noble C, et al. Over-expressed, N-terminally truncated BRAF is detected in the nucleus of cells with nuclear phosphorylated MEK and ERK. Heliyon. 2018;4(12):e01065doi: 10.1016/j.heliyon.2018.e01065.
Hey, F., Andreadi, C., Noble, C., Patel, B., Jin, H., Kamata, T., Straatman, K., Luo, J., Balmanno, K., Jones, D. T. W., Collins, V. P., Cook, S. J., Caunt, C. J., & Pritchard, C. (2018). Over-expressed, N-terminally truncated BRAF is detected in the nucleus of cells with nuclear phosphorylated MEK and ERK. Heliyon, 4(12), e01065. https://doi.org/10.1016/j.heliyon.2018.e01065
Hey, Fiona, et al. "Over-expressed, N-terminally truncated BRAF is detected in the nucleus of cells with nuclear phosphorylated MEK and ERK." Heliyon vol. 4,12 (2018): e01065. doi: https://doi.org/10.1016/j.heliyon.2018.e01065
Hey F, Andreadi C, Noble C, Patel B, Jin H, Kamata T, Straatman K, Luo J, Balmanno K, Jones DTW, Collins VP, Cook SJ, Caunt CJ, Pritchard C. Over-expressed, N-terminally truncated BRAF is detected in the nucleus of cells with nuclear phosphorylated MEK and ERK. Heliyon. 2018 Dec 20;4(12):e01065. doi: 10.1016/j.heliyon.2018.e01065. eCollection 2018 Dec. PMID: 30603699; PMCID: PMC6304467.
Copy Download .nbib Format: NLM
Hydrogen Dynamics in Supercritical Water Probed by Neutron Scattering and Computer Simulations.

The journal of physical chemistry letters

Andreani C, Romanelli G, Parmentier A, Senesi R, Kolesnikov AI, Ko HY, Calegari Andrade MF, Car R.
PMID: 33108193
J Phys Chem Lett. 2020 Nov 05;11(21):9461-9467. doi: 10.1021/acs.jpclett.0c02547. Epub 2020 Oct 27.

In this work, an investigation of supercritical water is presented combining inelastic and deep inelastic neutron scattering experiments and molecular dynamics simulations based on a machine-learned potential of

Cite
Andreani C, Romanelli G, Parmentier A, et al. Hydrogen Dynamics in Supercritical Water Probed by Neutron Scattering and Computer Simulations. J Phys Chem Lett. 2020;11(21):9461-9467doi: 10.1021/acs.jpclett.0c02547.
Andreani, C., Romanelli, G., Parmentier, A., Senesi, R., Kolesnikov, A. I., Ko, H. Y., Calegari Andrade, M. F., & Car, R. (2020). Hydrogen Dynamics in Supercritical Water Probed by Neutron Scattering and Computer Simulations. The journal of physical chemistry letters, 11(21), 9461-9467. https://doi.org/10.1021/acs.jpclett.0c02547
Andreani, Carla, et al. "Hydrogen Dynamics in Supercritical Water Probed by Neutron Scattering and Computer Simulations." The journal of physical chemistry letters vol. 11,21 (2020): 9461-9467. doi: https://doi.org/10.1021/acs.jpclett.0c02547
Andreani C, Romanelli G, Parmentier A, Senesi R, Kolesnikov AI, Ko HY, Calegari Andrade MF, Car R. Hydrogen Dynamics in Supercritical Water Probed by Neutron Scattering and Computer Simulations. J Phys Chem Lett. 2020 Nov 05;11(21):9461-9467. doi: 10.1021/acs.jpclett.0c02547. Epub 2020 Oct 27. PMID: 33108193.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 84 entries